Skip to content

Diagnostic and Imaging Indicators of Immunocardiomyopathic Patients

Multimodal Imaging Evaluation of Myocardial Involvement in Immunocardiomyopathic Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03885375
Enrollment
100
Registered
2019-03-21
Start date
2018-04-01
Completion date
2020-04-30
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Diseases

Brief summary

Cardiac involvements in autoimmune diseases (AD) is common but underestimated and an early detection remains a clinical challenge for lacking of efficient imaging methods. The objective of the study was to investigate LV myocardial abnormalities in AD patients by multimodal cardiac imaging, including speckle-tracking echocardiology (STE), cardiac magnetic resonance imaging (CMRI) and positron emission tomography (PET).

Interventions

None listed

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patient is diagnosed with autoimmune diseases, including systemic lupus erythematosus (SLE), vasculitis, dermatomyositis, sjogren's syndrome, scleroderma, rheumatoid arthritis and IgG4 associated disease. * Patient is capable of complying with study procedures

Exclusion criteria

* Patient is pregnant or nursing * Patient is complicated with congenital heart disease * Patient had cardiac surgery before * Patient is complicated with serious infections * Patient is complicated with organ failure * Patient is complicated with tumors * Patient is diagnosed indefinitely * Patient has been involved in other clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Change in deformational parameters in echocardiography during follow-up period6 months - 1 year - 2 yearsglobal longitudinal strain (%), circumferential strain (%) and radial strain (%) measured by STE in autoimmune diseases
Progression of myocardial fibrosis and edema during follow-up period1 year - 2 yearsLate Gadolinium Enhanced, T1 mapping and T2 mapping tested by CMRI
Change in myocardial perfusion during follow-up period1 year - 2 yearsSUVmax examined by PET

Countries

China

Contacts

Primary ContactWei Chen, MD
chen_wei0201@aliyun.com13911363358

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026